6 completed, 1 terminated, 1 withdrawn. 6 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Withdrawn 1 |
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Bionomics Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1 225 mg BNC210, Placebo - Social Anxiety Disorder | Phase 3 | Completed | Bionomics Limited | 370 | 2024-08-06 | 2026-05-19 |
| A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder 225 mg BNC210, 675 mg BNC210, Placebo - Social Anxiety Disorder | Phase 2 | Completed | Bionomics Limited | 151 | 2022-02-02 | 2025-03-18 |
| A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD) BNC210, Placebo - Post-Traumatic Stress Disorder | Phase 2 | Completed | Bionomics Limited | 212 | 2021-07-27 | 2025-02-06 |
| A Study of BNC210 in Elderly Patients With Agitation BNC210, Placebo - Agitation in the Elderly | Phase 2 | Completed | Bionomics Limited | 38 | 2018-05-17 | 2020-07-09 |
| Phase II Study of BNC210 in PTSD BNC210, Placebo - Post-Traumatic Stress Disorder | Phase 2 | Completed | Bionomics Limited | 193 | 2016-06-30 | 2023-02-27 |
| A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer. BNC101 Solution for Infusion, BNC101 in combination with FOLFIRI - Colorectal Cancer | Phase 1 | Terminated | Bionomics Limited | 22 | 2016-03-01 | 2019-01-16 |
| BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients Carboplatin, Gemcitabine, BNC105P - Ovarian Cancer | Phase 1 / Phase 2 | Withdrawn | Hoosier Cancer Research Network | 2012-10-01 | 2015-12-23 | |
| BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Everolimus, BNC105P - Renal Cell Carcinoma | Phase 1 / Phase 2 | Completed | Hoosier Cancer Research Network | 154 | 2010-01-01 | 2022-07-11 |
Phobia, Social (2) · Stress Disorders, Post-Traumatic (2) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1)
BNC 105P (2) · Carboplatin (1) · Everolimus (1) · Gemcitabine (1) · IFL protocol (1)
United States (6) · Australia (5) · New Zealand (1) · Singapore (1) · United Kingdom (1)
Daniela Matei, M.D. (1) · Danny Rischin, Professor (1) · Thomas Hutson, D.O. (1)